Stevanato Group Publishes Materials for 2022 Annual General Meeting
May 06 2022 - 4:05PM
Business Wire
Stevanato Group, a global provider of drug containment, drug
delivery and diagnostic solutions to the pharmaceutical,
biotechnology and life sciences industries, announced today that it
has published the agenda for the 2022 Annual General Meeting of
Shareholders (“AGM”), which will be held virtually on June 1, 2022,
beginning at 4:00 p.m. (CEST) / 10:00 a.m. (EDT).
Stevanato Group’s AGM notice, explanatory notes, other AGM
materials, and instructions for voting, are available on the
investors section of Stevanato Group’s corporate website at
https://ir.stevanatogroup.com/, under the governance section, where
they can be viewed and downloaded. Shareholders may request a hard
copy of these materials, which includes the audited financial
statements, free of charge, by emailing
legal@stevanatogroup.com.
About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of
drug containment, drug delivery and diagnostic solutions to the
pharmaceutical, biotechnology and life sciences industries. The
Group delivers an integrated, end-to-end portfolio of products,
processes and services that address customer needs across the
entire drug life cycle at each of the development, clinical and
commercial stages. Stevanato Group’s core capabilities in
scientific research and development, its commitment to technical
innovation and its engineering excellence are central to its
ability to offer value added solutions to clients. To learn more,
visit www.stevanatogroup.com.
Forward-Looking Statements
This press release may include forward-looking statements. The
words “will”, "can" and similar expressions (or their negative)
identify certain of these forward-looking statements.
Forward-looking statements contained in this press release may
include, but are not limited to, statements about Stevanato Group's
AGM and our future financial performance. These statements are
neither promise nor guarantee but involve known and unknown risks,
uncertainties and other important factors and circumstances that
may cause Stevanato Group’s actual results, performance or
achievements to be materially different from its expectations
expressed or implied by the forward-looking statements, including
conditions in the U.S. capital markets, negative global economic
conditions, inflation, potential negative developments in the
COVID-19 pandemic, the impact of the conflict between Russia and
Ukraine, supply chain challenges and other negative developments in
Stevanato Group’s business or unfavorable legislative or regulatory
developments. The forward-looking statements speak only as at their
dates. The Company undertakes no obligation to update any
forward-looking statement or statements to reflect events or
circumstances after the date on which such statement is made or to
reflect the occurrence of unanticipated events. New factors emerge
from time to time, and it is not possible to predict all of these
factors. Further, the Company cannot assess the impact of each such
factor on our business or the extent to which any factor, or
combination of factors, may cause actual results to be materially
different from those contained in any forward-looking statements.
We caution you therefore against relying on these forward-looking
statements, and we qualify all of our forward-looking statements by
these cautionary statements.
Important factors that could cause actual results to differ
materially from those discussed in the forward‐looking statements
can be found under the heading "Risk Factors" in our most recent
reports on Form 20-F and other documents of Stevanato Group on file
with the U.S. Securities and Exchange Commission.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220506005270/en/
Media Stevanato Group: media@stevanatogroup.com Investor
Relations Lisa Miles: lisa.miles@stevanatogroup.com
Stevanato (NYSE:STVN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Stevanato (NYSE:STVN)
Historical Stock Chart
From Sep 2023 to Sep 2024